Thursday, April 03, 2025 1:49:51 PM
How about LP providing the real story on a lot of subjects outside the MHRA?
What is up with the disconnect between the hundreds of patients treated by specials in the last several years and the measly reported revenue? Either the LG number is BS or something is very wrong with the Advent deal.
What is up with Eden being on hold until the C cleanroom(s) are operational? First, most thought the C cleanrooms were actually being built. Some thought they were complete. And now we know that is hold and they might start constructing a "simplified" C in "the coming months". And Eden will not be ordered until they expect that operational, which will be a year out or more. WTF?
And also on Eden, what was the functionality important enough to redesign the prototype to include, but now not implemented due to size?
Why no clarity of the actual Roswell agents in licensed?
What are the plans to submit to either of the two main agencies (EMA/FDA)? Every single company I know has kept shareholders informed on this from shortly after a successful P3.
What is up with the disconnect between the hundreds of patients treated by specials in the last several years and the measly reported revenue? Either the LG number is BS or something is very wrong with the Advent deal.
What is up with Eden being on hold until the C cleanroom(s) are operational? First, most thought the C cleanrooms were actually being built. Some thought they were complete. And now we know that is hold and they might start constructing a "simplified" C in "the coming months". And Eden will not be ordered until they expect that operational, which will be a year out or more. WTF?
And also on Eden, what was the functionality important enough to redesign the prototype to include, but now not implemented due to size?
Why no clarity of the actual Roswell agents in licensed?
What are the plans to submit to either of the two main agencies (EMA/FDA)? Every single company I know has kept shareholders informed on this from shortly after a successful P3.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
